Monday, May 23, 2022
  • Login
CEO North America
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • Executive Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • Executive Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
CEO North America
No Result
View All Result

Vaccines aren’t the end of the fight

in Innovation
- vaccines aren’t the end of the fight
Share on FacebookShare on Twitter

Governments cannot let the most vulnerable be the least protected again.

Boston Consulting Article by Johanna Benesty, Marin Gjaja, Dan Kahn, Josh Kellar, Ben Keneally, Rich Lesser, Jonathan Scott, and Emily Serazin 

The pivotal Phase III trials of COVID-19 vaccine candidates are nearing the first results, and hopes are rising that the end of the worst pandemic in a century may be approaching. These understandable hopes must be tempered by the complexities of defeating this virus. Countries are still only months into a very long fight.

Even with a highly successful vaccine rollout—the bull case—the public will still be wearing masks, maintaining distance, and avoiding crowds for many months after regulatory authorization. In fact, the public will likely be taking these precautions into the second half of 2021 or longer. Testing, tracing, and continuing efforts to reduce the severity of the disease with therapeutics will also remain crucial. If the rollout is less successful—the base and bear cases—such interventions could stay in place for 15 more months or longer. (See “The Bull, Base, and Bear Cases.”)

The rollout needs to happen both efficiently and equitably. We will have failed if vaccines disproportionately flow to wealthy nations and individuals at the expense of nations with low or midrange per capita income and marginalized communities. Governments cannot repeat the mistakes made during the early days of the pandemic, when the most vulnerable were the least protected from the virus. Countries, regions, and states still have time to get this right through science, hard work, and vigilance.

For public health officials, who have been on the frontlines all year, the work enters the next crucial phase. In countries that have contained the virus, winning the health endgame will cement trust and legitimacy, creating a platform on which to build economic recovery. For countries that have struggled with their public health response, this phase is the opportunity to flip the script and restore faith in the government.

Where the world stands

The response to the coronavirus is proceeding in three phases—flatten, fight, and future. The world is still in the early stages of the fight phase, which began when nations restarted activity to end the flatten (or lockdown) phase. Rolling out vaccines and improving therapeutics will help us accelerate the fight, while crush-and-contain strategies and smart government policies will help manage further impact.

Ten novel COVID-19 vaccine candidates have entered Phase III clinical trials across the globe less than nine months after the sequencing of the virus genome. Many more are close behind. The US Food and Drug Administration (FDA) and the European Medicines Agency could grant emergency-use authorizations as soon as November 2020. The Chinese and Russian governments have already approved five vaccines for emergency use.

These authorizations start the clock on the hard work of rolling out vaccines to a global population in an orderly and scientific sequence that prioritizes protecting the health vulnerable and those who have a high risk of exposure. What happens in low-income nations matters for humanitarian and practical reasons. In an interconnected world of global trade and tourism, fully restoring a country’s economic, social, and public health depends on a global recovery that includes all nations.

Likewise, the rollout of vaccines requires the near-flawless execution of an interconnected chain of processes. Because of the vagaries of manufacturing vaccines, there is a saying in the scientific community that “the process is the product.” In the case of COVID-19 vaccines, this aphorism extends to every aspect of the rollout: distribution, the supply of glass vials and syringes, ultracold storage, public education and outreach, record keeping and follow-up, and safety and efficacy monitoring.

Four known vaccine “unknowns”—availability, effectiveness, safety, and uptake—will determine how swiftly this happens. More here.

Tags: BCGBoston Consulting GroupCEOCEO NorthamPandemicVaccines

Related Posts

Five rules for fixing ai in business
Innovation

Five Rules for Fixing AI in Business

Pandemic’s e-commerce surge proves less persistent, more varied
Innovation

Pandemic’s E-commerce Surge Proves Less Persistent, More Varied

Mit: ukrainians who engage in more analytic thinking are less susceptible to russia’s disinformation campaign
Innovation

MIT: Ukrainians who engage in more analytic thinking are less susceptible to Russia’s disinformation campaign

The ceo agenda for an era of innovation without borders
Innovation

The CEO Agenda for an Era of Innovation Without Borders

Atlanta fed: contactless card pay more than doubled in 2020, but from small base
Innovation

Atlanta Fed: Contactless Card Pay More than Doubled in 2020, but from Small Base

How public-private ecosystems can help solve societal problems
Innovation

How Public-Private Ecosystems Can Help Solve Societal Problems

Don’t just adopt cloud computing, adapt to it
Innovation

Don’t just adopt cloud computing, adapt to it

Our children are growing up with ai. Here’s what you need to know. 
Innovation

Our children are growing up with AI. Here’s what you need to know.

State of climate tech 2022
Innovation

State of climate tech 2022

Living in a world of unicorns
Innovation

Living in a world of unicorns

No Result
View All Result

Recent Posts

  • Russia Halts Gas Supplies to Finland
  • McDonald’s to Sell Restaurants to Russian Operator
  • Vintage Mercedes Sells for $143 million
  • Ignoring AI Is Risky Business for Insurance CEOs
  • UNWTO Launches Digital Futures Programme for SMEs

Recent Comments

    Archives

    Categories

    • Art & Culture
    • Business
    • CEO Life
    • Editor´s Choice
    • Entrepreneur
    • Environment
    • Executive Interviews
    • Food
    • Health
    • Highlights
    • Industry
    • Innovation
    • Issues
    • Management & Leadership
    • Multimedia
    • News
    • Opinion
    • PrimeZone
    • Printed Version
    • Travel
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    CEO Latin America | ES

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

     

    AUSTIN

    600, Congress Avenue 14th Floor
    Austin, TX.
    78701
    USA
    +1 512 649 0340

    NEW YORK

    387 Park Ave South,
    New York, NY.
    10016
    USA
    +1 212 796 64 15

    CEO North America © 2022 - Sitemap

    No Result
    View All Result
    • Home
    • Business
      • Entrepreneur
      • Industry
      • Innovation
      • Management & Leadership
    • Executive Interviews
    • CEO Life
      • Art & Culture
      • Food
      • Health
      • Travel
      • Environment
    • Opinion
    • News
    • Multimedia

    © 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    Are you sure want to unlock this post?
    Unlock left : 0
    Are you sure want to cancel subscription?